| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c0b5bbccb736c3c58205a0abd1eabca0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b80acf1b8ddebaf40fde99a66dc930df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1ec784dd71bb997752408c11ce9f77cc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b9381460b5e2a1871f21778aadaae228
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_77565f01d0e43e53a53f56103eb7e29c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ad232699e22c367da9e042eadae4cf99 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-042 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L15-00 |
| filingDate |
2011-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d16ee895d5b8beb495e5bfdafb521a5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3506f3ba41abea280468879f4fde8f2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6774e4c97afb668e331d1d52a578ddac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02713a64880d7f623b68df81d40c1e10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71b8c60b85adf21be0a90bf9a18faffb |
| publicationDate |
2012-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2012024339-A1 |
| titleOfInvention |
Anti-adhesion alginate barrier of variable absorbance |
| abstract |
Described are mono- and bi-layer alginate post-surgical anti-adhesion barriers with tailored absorption profiles and non-migrating characteristics. Muco-adhesive propexties of alginates in their solid state are used to localize the device, and lubricious properties of alginates in their liquid state are used to mitigate adhesion formation during wound healing. In addition, the design of the implant can be selected such that the crosslinking agent is released from the device under specific conditions and the absorhance profile modified. A medicinal agent may optionally be incorporated. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10272184-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11565027-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016502874-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013033168-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10850011-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019081004-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018020213-A |
| priorityDate |
2010-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |